Klaus A M, Hapke H J
Institut für Pharmakologie, Toxikologie und Pharmazie, Tierärztlichen Hochschule Hannover.
Dtsch Tierarztl Wochenschr. 1994 Aug;101(8):331-8.
Drug treatment of horses which are used in horse-racing is restricted by the regulations of the anti-doping control. Veterinarians and anti-doping control commissions are faced with the problems resulting from the discrepancy between the demand "no drugs in blood/urine of horses at the time of competition" and the need for treatment. The pharmacokinetic data of important antiphlogistics/analgetics (NSAID) for horses given in this article shall facilitate the decision of the veterinarians and commissions whether a horse having been treated with NSAID may participate in a competition or not. Further a new concept of anti-doping regulation of therapeutic substances is presented for discussion.
赛马用马匹的药物治疗受到反兴奋剂控制法规的限制。兽医和反兴奋剂控制委员会面临着“比赛时马匹血液/尿液中无药物”这一要求与治疗需求之间差异所导致的问题。本文给出的马匹重要消炎/镇痛药(非甾体抗炎药)的药代动力学数据,将有助于兽医和委员会决定一匹接受过非甾体抗炎药治疗的马是否可以参加比赛。此外,还提出了一个关于治疗性物质反兴奋剂监管的新概念以供讨论。